There are two broad classes of receptors in the brain, and the distinction matters clinically. The class determines the timescale of the drug's effect — milliseconds versus weeks — and predicts whether a medication will produce rapid relief or require sustained dosing to work.
Ionotropic receptors are themselves ion channels. When the neurotransmitter binds, the channel opens, ions flow across the membrane, and the postsynaptic neuron is depolarized or hyperpolarized within milliseconds. The effect is immediate and brief. Ionotropic receptors include:
GABA-A receptor — a chloride channel. When GABA binds, chloride flows into the neuron, hyperpolarizing it, producing fast inhibition. Benzodiazepines, alcohol, and barbiturates all enhance this receptor's activity, producing rapid sedation and anxiolysis.
NMDA glutamate receptor — a calcium and sodium channel. When glutamate binds (and the membrane is sufficiently depolarized to release the magnesium block), the channel opens. Ketamine and PCP block this receptor, producing dissociation, anesthesia, and (paradoxically) rapid antidepressant effects.
AMPA glutamate receptor — a sodium channel. The workhorse of fast excitatory transmission throughout the brain.
Nicotinic acetylcholine receptors — sodium and potassium channels. The receptors at the neuromuscular junction and at central sites that nicotine activates.
Ionotropic receptors are fast. Drugs targeting them can produce effects in seconds to minutes. Benzodiazepines for acute anxiety work in 10-20 minutes. Ketamine antidepressant effects start within hours. Anesthesia happens in seconds.
Metabotropic receptors are G-protein-coupled. When the neurotransmitter binds, the receptor activates an intracellular G-protein, which then triggers cascades involving second messengers like cyclic AMP, inositol trisphosphate, and diacylglycerol. These cascades change the cell's behavior over seconds, minutes, hours, and eventually days through gene transcription and protein synthesis. Metabotropic receptors include:
Dopamine D1 through D5 receptors — all metabotropic. D1/D5 couple to Gs (excitatory cascade); D2/D3/D4 couple to Gi (inhibitory cascade).
Serotonin receptors except 5-HT3 — most serotonin receptor subtypes are metabotropic. The 5-HT3 receptor is the exception, being ionotropic (it is the target of ondansetron for nausea).
Norepinephrine alpha and beta receptors — all metabotropic.
Muscarinic acetylcholine receptors (M1-M5) — all metabotropic.
Opioid mu, kappa, and delta receptors — all metabotropic.
Most of psychiatry's targets are metabotropic, which is part of why most psychiatric medications take weeks to work. They are inducing slow changes in cell behavior, gene expression, and synaptic plasticity, not just opening ion channels. The therapeutic effect of an SSRI emerges over four to six weeks because metabotropic 5-HT receptor activation gradually downregulates autoreceptors, changes gene expression in hippocampal and prefrontal neurons, and reshapes synaptic connectivity in mood-regulating circuits.
Hold the distinction. Ionotropic equals fast. Metabotropic equals slow. The class of the target receptor predicts how quickly the medication will work and through what kind of cellular changes.